Zsuzsanna Nagy, PhD

Zsuzsi is a scientist in Medicine at Dana-Farber Cancer Institute and Harvard Medical School. She received her Master’s and PhD degree in biomedical sciences from the University of Debrecen (Debrecen, Hungary). She then completed her postdoctoral studies at the Macquarie University and Children’s Cancer Institute in Sydney, Australia. Zsuzsi’s is currently investigating the epigenetic factors underlying the action of acquired therapy resistance in breast cancer. Her main research project focuses on characterizing the activity of ESR1 fusions in estrogen receptor positive breast cancer.